Email this article The Production and Characteristics of a Mouse’s Embryonic Stem Cell Lineage, Transfected by the Glia Neurotrophic Factor and Gene Fused with the Green Fluorescent Protein Gene
- Authors: Arsenieva EL1,2, Kuzmin IV1,2, Manuilova ES1,2, Novosadova EV1,2, Murkin EV1,2, Pavlova GV1,2, Tarantul VZ1,2, Grivennikov IA1,2
-
Affiliations:
- Molecular Genetics Institute, Russian Academy of Sciences
- Gene Biology Institute, Russian Academy of Sciences
- Issue: Vol 1, No 1 (2009)
- Pages: 109-114
- Section: Articles
- URL: https://actanaturae.ru/2075-8251/article/view/10831
- DOI: https://doi.org/10.32607/20758251-2009-1-1-109-114
- ID: 10831
Cite item
Abstract
The influence that the expression of the human (glial-derived neurotrophic factor (GDNF)) neurotrophic factor has on the morphology and proliferative activity of embryonic stem cells (SC) of a mouse with R1 lineage, as well as their ability to form embroid bodies (EB), has been studied. Before that, using a PCR (polymerase chain reaction) coupled with reverse transcription, it was shown that, in this very lineage of the embryonic SC, the expression of the receptors’ genes is being fulfilled for the neurotropfic RET and GFRα1 glia factor. The mouse's embryonic SC lineage has been obtained, transfected by the human GDNF gene, and has been fused with the “green” fluorescent protein (GFP) gene. The presence of the expression of the human GDNF gene in the cells was shown by northern hybridization and the synthesis of its albuminous product by immunocitochemical coloration with the use of specific antibodies. The reliable slowing-down of the embriod-body formation by the embryonic SC transfected by the GDNF gene has been shown. No significant influence of the expression of the GDNF gene on the morphology and the proliferative activity of the transfected embryonic SCs has been found when compared with the control ones.
Full Text
Glial-derived neurotrophic factor (GDNF) belongs to the GDNF-similar ligand (GFL) family, which includes neurturin (NRTN ), persipin (PSPN), and artemin (ARTN ). All of these are necessary for the survival of the dopaminergic neurons of the mesencephalon, as well as for peripheral sensory and sympathetic neurons (with the exception of PSPN) [12, 14]. In addition, beyond the nervous system, GDNF fulfills the following important functions: it regulates the differentiation of spermatogonia and is needed for the embryonic development of kidneys [14]. All representatives of the GFL family influence the cells through bonding with the heteroreceptor complex, which contains the RET receptor and GFRα co-receptor [14]. The specificity of the RET receptor activation, in relation to different factors of the GFL family, depends on the GFRα type 110 | Acta naturae | № 1 2009 RE SEARC H ART ICLES contained in the cells. GDNF, NRTN , ARTN , and PSPN have strong affinities to GFRα1, GFRα2, GFRα3, and GFRα4 coreceptors, respectively. GFL binding with the “alien” GFRα is possible, but it happens with less efficiency. It has been shown that GDNF increases the survival rate of the dopaminergic neurons of rats’ embryonic mesencephalon in a specific way, making the dopamine metabolism stronger; it also increases the differentiation level of tyrosine hydroxilasepositive cells (TH-), raising the axons’ growth and increasing the dimensions of the cell’s body. Analogous effects have also been observed in rats’ mesencephalon dopaminergic neurons [12]. Similar results have been obtained on fruitfly transgenic lines. It appeared that a distinct synthesis of tyrosine hydroxilase has been found in the fruit fly’s lines bearing the GDNF gene and in differentiating nerve cells, and the fruit fly’s cells bearing the GDNF gene were actively producing acetylcholinesterase [2, 3] Embryonic SCs are able to self-renew and differentiate to the derivatives of all three primary embryonic leaves both in vitro and in vivo. Most importantly, in the course of the embryonic SCs, the differentiation of the order of expression and the tissue-specific genes correspond to the order of these processes during the development of the organism in vivo [7].×
About the authors
E L Arsenieva
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
I V Kuzmin
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
E S Manuilova
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
E V Novosadova
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
E V Murkin
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
G V Pavlova
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
V Z Tarantul
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
I A Grivennikov
Molecular Genetics Institute, Russian Academy of Sciences; Gene Biology Institute, Russian Academy of Sciences
Email: igorag@img.ras.ru
Moscow
References
- E.S.Manuilova, E.L.Arsenieva, N.V.Khaidarova et al // Ontogenesis. 2003. Vol. 34, No 3, pages 204-210.
- G.V.Pavlova, E.A.Modestova, S.P.Vengrova et al // Academy of Sciences Reports, 2001, Vol.376, No5, pages 694-696.
- G.V.Pavlova, A.A.Yefanov, V.N.Bashkirov et al // Cytology. 2002. Vol.44, No11.P 11041108.
- Bain G., Kitchens D., Yao M., Huettner J.E., Gottlieb D.I. // Dev Biol. 1995. Vol. 168, N 2. P. 342-357.
- Buytaert-Hoefen K.A., Alvarez E., Freed C.R. // Stem cells. 2004. Vol. 22, N 5. P. 669674.
- Fraichard A.,Chassande O., Bilbaut G. et al. // J. Cell Sci. 1995. Vol. 108, N 10. P. 31813186.
- Guan K., Rohwedel J., Wobus A.M. // Cytotechnology. 1999. Vol. 30, N 4. P. 211-226.
- Kawai K, Iwashita T, Murakami H. et al. // Cancer Res. 2000. 15. Vol. 60, N 18. P. 52545260.
- Kawasaki H., Mizuseki K., Nishikawa S. et al. // Neuron. 2000. Vol. 28, N 1. P. 31-40.
- Kim J.H., Auerbach J.M., Rodrigues-Gomez J.A. et al. // Nature. 2002. Vol. 418, N 6893. P. 50-56.
- Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. // J. Clin. Invest. 1996. Vol. 98, N 1. P.216-224.
- Lin L.F., Doherty D.H., Lile J.D. et al. // Science. 1993. Vol. 260, N 5111. P. 1130-1132.
- Manuilova E.S., Arsenyeva E.L., Khaidarova N.V et al. // IJBS. 2008. Vol. 4, N 1. P.29-37.
- Sariola H., Saarma M. // J. Cell Sci. 2003. Vol.116, N 19. P. 3855-3862.
- Roche E., Soria B., Berna G. et al. // Diabetes. 2000. Vol. 49, N 2. P. 157-162.
- Wiles M.V., Keller G. // Development. 1991. Vol. 11, N 2. P. 259-267.
- Yue F., Cui L., Johkura K. // Stem cells. 2006. Vol. 24, N 7. P. 1625-1706.
- Zeng X, Cai J, Chen J et al. // Stem cells. 2004. Vol. 22, N 6. P. 925-940.
Supplementary files
